EUVIMEDOpdag EUVIMED
ÜbersichtsarbeitOpen access · CC BY-NC-ND 4.0

Chromatography in Downstream Processing of Recombinant Adeno‐Associated Viruses: A Review of Current and Future Practises

Julius Klemens Lorek, Madelène Isaksson, Bernt Nilsson

Biotechnology and Bioengineering · 2025-05 · 122 (5) · 1067-1086

DOI: 10.1002/bit.28932 ↗

At a glance

Übersichtsarbeit in Biotechnology and Bioengineering, published online on 2025-02-04. Written by Julius Klemens Lorek and 2 co-authors. Institution: Department of Process and Life Science Engineering, Lund University, Lund, Sweden. Major MEDLINE topics: Dependovirus, Genetic Vectors, Chromatography. Cited 21 times so far (Crossref); 218 references. The full text is freely available (open access, CC BY-NC-ND 4.0).

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Recombinant adeno‐associated virus (rAAV) has emerged as an attractive gene delivery vector platform to treat both rare and pervasive diseases. With more and more rAAV‐based therapies entering late‐stage clinical trials and commercialization, there is an increasing pressure on the rAAV manufacturing process to accelerate drug development, account for larger trials, and commercially provide high doses. Still, many of the pre‐clinical and clinical manufacturing processes are tied to outdated technologies, which results in substantial production expenses. Those processes face challenges including low productivity and difficult scalability, which limits its ability to provide for required dosages which in turn influences the accessibility of the drug. And as upstream efforts are expected to increase productivities, the downstream part needs to adapt with more scalable and efficient technologies. In this review, both traditional and novel rAAV downstream technologies are presented and discussed. Traditional rAAV downstream processes are based on density gradient ultracentrifugation and have been shown to effectively purify rAAVs with high yields and purities. However, those processes lack scalability and efficiency, which is why novel rAAV downstream processes based on column‐chromatography have emerged as an attractive alternative and show potential for integration in continuous processes, following the principle of next‐generation manufacturing.

Subjects

MeSH terms (MEDLINE)

DependovirusGenetic VectorsChromatographyHumansGenetic Therapy

Author keywords

column‐chromatographycontinuous biomanufacturinggene therapyrAAV downstream processingrAAV manufacturingrecombinant Adeno‐associated virus

Authors and institutions

  • Department of Process and Life Science Engineering, Lund University, Lund, Sweden.

Cite

APA

Lorek, J. K., Isaksson, M., & Nilsson, B. (2025). Chromatography in Downstream Processing of Recombinant Adeno‐Associated Viruses: A Review of Current and Future Practises. Biotechnology and Bioengineering, 122(5), 1067-1086. https://doi.org/10.1002/bit.28932

Vancouver

Lorek JK, Isaksson M, Nilsson B. Chromatography in Downstream Processing of Recombinant Adeno‐Associated Viruses: A Review of Current and Future Practises. Biotechnology and Bioengineering. 2025;122(5):1067-1086. doi:10.1002/bit.28932

BibTeX
@article{Lorek2025,
  author = {Lorek, Julius Klemens and Isaksson, Madelène and Nilsson, Bernt},
  title = {Chromatography in Downstream Processing of Recombinant Adeno‐Associated Viruses: A Review of Current and Future Practises},
  journal = {Biotechnology and Bioengineering},
  year = {2025},
  volume = {122},
  number = {5},
  pages = {1067--1086},
  doi = {10.1002/bit.28932}
}
Start for free →